Trial intelligence / Profile preview

Intranasal insulin for prevention of postoperative delirium after cardiac surgery

jRCTs031230047Recruiting

Sponsor
Department fund (Department of Anesthesiology, University of Tsukuba)
Start
Jul 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in postoperative delirium (POD) comparing Intranasal insulin with Placebo control (2 arms). Primary endpoint: Incidence of delirium within 7 days after surgery. Started Jul 2023; status: recruiting.

02

Drugs

human insulin
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on jRCTs031230047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031230047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call